Trademark Alertz ®
Search
Trademark
Owner
Trademark: TRIGENESIS 2138720
Word
TRIGENESIS
ID
2138720
Trademark Type
Word
Status
Cancelled: Cancelled at the request of IB
Application Date
20 July 2020
Registration Date
20 July 2020
Cancellation Date
24 August 2023
Owner(s)
Sarepta Therapeutics, Inc.
Service
Goods and Services:
Class 5
:
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders
;
pharmaceutical preparations based on morpholino oligomer technology platform
;
pharmaceutical preparations that modulate RNA expression
;
gene therapy products, namely, gene delivery pharmaceuticals
;
pharmaceutical preparations for gene therapy, gene editing, and genome editing
;
gene therapy products for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders
;
biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders
;
viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders
;
pharmaceutical preparations, biological preparations and gene therapy products for the treatment of genetic disorders and diseases.
Class 16
:
Printed materials, namely, brochures, leaflets, reports, and newsletters on the topics of medicine, medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, rare and infectious diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, genetic therapy research, and diagnosis and treatment of genetic disorders.
Class 42
:
Medical research
;
medical and scientific research services all in the field of rare and infectious diseases
;
medical and scientific research services all in the field of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, and genetic diseases and disorders
;
medical and scientific research services all in the field of gene therapy, gene editing, genome editing, viruses, viral vectors, and viral constructs
;
providing information in the field of medical research, scientific research, research and development relating to pharmaceuticals, biological preparations and gene therapy products, rare and infectious diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, genetic therapy research, and diagnosis and treatment of genetic disorders via a website.
Class 44
:
Medical information services
;
providing medical information via a website
;
provision of health care services, namely, providing information to doctors and patients regarding rare diseases, medicines, health conditions and treatment options.